Clinical Trial Update: Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor [EARLY_Phase 1]

View source ↗

Summary

This early-phase 1 clinical trial update describes a combination of irinotecan, temozolomide, and bevacizumab with high-dose alkylator chemotherapy for newly di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoplastic Small Round Cell Tumor
• Sarcoma

Drugs mentioned

• Bevacizumab (Avastin) (bevacizumab)
• Irinotecan (Camptosar) (Irinotecan)
• Temozolomide (Temodar) (Temozolomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Sarcoma, Desmoplastic Small Round Cell Tumor (DSRCT) | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING